LL-37 (Cap-18) Nasal Spray
LL-37 (CAP-18) is supplied by Direct SARMs Iceland as a pre-mixed liquid nasal spray in 15ml and 30ml formats containing a synthetic peptide for laboratory research purposes only, and is available from Direct SARMs in 15 ml and 30 ml sizes.
98.0% purityBatch COA includedStore 2–8°C
Price range: $58.55 through $110.85
Buy more, save more
7.5% offspend $250.00
12.5% offspend $400.00
Spend $250.00 for 7.5% off on qualifying items · Applied automatically at checkout
Researchers who bought LL-37 (Cap-18) Nasal Spray also bought
LL-37 (Cap-18) Nasal Spray
LL-37 (CAP-18) is a synthetic form of the human cathelicidin antimicrobial peptide referenced throughout scientific literature examining innate immunity, host defence, epithelial biology, and cellular signalling. Direct SARMs Iceland supplies LL-37 (CAP-18) as a pre-mixed liquid nasal spray containing 5mg in the 15ml format and 10mg in the 30ml format. HPLC documentation and a Certificate of Analysis (COA) accompany the material to assist laboratory identification, analytical verification, and research record documentation.
Benefits of the nasal spray format
1
The dispensing is pre-measured. Each time the spray mechanism is actuated, it releases a constant volume, which allows for repeatable dispensing when carrying out research procedures.
2
Convenient format. Compact spray bottles are straightforward to store, handle, and transport within an appropriate research environment.
3
Ready to use. Unlike lyophilized peptides, which are provided in vials, nasal spray formulations are in liquid form and do not need to be reconstituted before being handled in the laboratory.
4
Protected storage. The bottle protects the formulation by preventing unnecessary handling and exposure to the environment between research procedures.
5
Simple dispensing. The product can be dispensed easily. With an integrated spraying mechanism, it is not necessary to draw the liquid from a vial, offering a simple way to dispense the formulation during research.
Visit the LL-37 (CAP-18) Peptide Research Hub ▸
LL-37 (Cap-18) is supplied exclusively for laboratory research use. The information on this page is provided for scientific and educational reference and is based on available published research. This product is not intended for human or veterinary use, diagnosis, treatment, or prevention of any disease or medical condition. It is intended solely for qualified laboratory research and must be handled in accordance with applicable laboratory safety requirements.
Buy LL-37 (Cap-18) Nasal Spray Iceland from Direct SARMS.
Additional information
| 15ml Size | Contains 5mg LL-37 (CAP-18) peptide |
| 30ml Size | Contains 10mg LL-37 (CAP-18) peptide |
| Purity | 98.0% |
| Molecular Formula | C205H340N60O53 |
| Molecular Weight | 4493.26 g/mol |
| Sequence(IUPAC) | Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Ala-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser |
| Physical Features | Pre-mixed liquid nasal spray |
General information
Applies to all Direct Sarms research compounds unless noted otherwise on the product.
Storage & handling
Store the nasal spray according to the instructions provided on the product label. Keep the bottle securely closed when not in use and protect it from excessive heat and direct light. Follow any product-specific refrigeration requirements stated on the label.
Shipping & discretion
Fully tracked dispatch with worldwide shipping available. Sent in plain, discreet outer packaging with no product description on the label.
FDA disclosure & intended use
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. Research use only — not for human or animal consumption. You must be 18+ and a qualified researcher.
Got a question about this LL-37 (Cap-18) compound?
A LL-37 (Cap-18) Nasal Spray is a product that is the result of research and is available in the form of a nasal spray for use in laboratory and analytical research; it is provided exclusively for research purposes and is not meant for human consumption.
The term "nasal spray" refers only to the form and manner in which the product is supplied and does not include any instructions or recommendations regarding its administration or use in humans.
LL-37 is a cationic antimicrobial peptide which has been the subject of scientific research concerning peptide structure, cellular signalling, and molecular interactions and it is derived from the human cathelicidin precursor protein hCAP-18.
No, this product is meant only for use in laboratory research and is not intended for human consumption or for any clinical, medical, or therapeutic purpose; furthermore, no instructions regarding dosing or administration are given.
Certificate of Analysis
| Identity | LL-37 (Cap-18) | CONFORMS |
| Purity (HPLC) | 98.0% | CONFORMS |
| Mass (LC-MS) | 4493.26 g/mol | CONFORMS |
